Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: SVP of $AORT (AORT) Sells 4,035 Shares

Jean F Holloway, the SVP of $AORT ($AORT), sold 4,035 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.5% of their shares....

AORT : 28.70 (+0.53%)
Insider Sale: VP of $AORT (AORT) Sells 4,329 Shares

Amy Horton, the VP of $AORT ($AORT), sold 4,329 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1% of their shares. Following...

AORT : 28.70 (+0.53%)
Artivion: Q3 Earnings Snapshot

Artivion: Q3 Earnings Snapshot

AORT : 28.70 (+0.53%)
Artivion: Q2 Earnings Snapshot

Artivion: Q2 Earnings Snapshot

AORT : 28.70 (+0.53%)
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2023...

AORT : 28.70 (+0.53%)
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its On-X...

AORT : 28.70 (+0.53%)
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today presented interim results from the...

AORT : 28.70 (+0.53%)
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at...

AORT : 28.70 (+0.53%)
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present...

AORT : 28.70 (+0.53%)
Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

AORT : 28.70 (+0.53%)

Barchart Exclusives

‘Five Day Loser’ Tyson Foods (TSN) Could Be Due for a Comeback Soon
Although TSN stock has been the victim of unusual volatility, the fading red ink could signal a potential rebound. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar